BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 10233416)

  • 1. Induction of BCR-ABL fusion genes by in vitro X-irradiation.
    Ito T; Seyama T; Mizuno T; Hayashi T; Iwamoto KS; Dohi K; Nakamura N; Akiyama M
    Jpn J Cancer Res; 1993 Feb; 84(2):105-9. PubMed ID: 8463127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the different BCR-ABL transcripts with a single multiplex RT-PCR.
    Chasseriau J; Rivet J; Bilan F; Chomel JC; Guilhot F; Bourmeyster N; Kitzis A
    J Mol Diagn; 2004 Nov; 6(4):343-7. PubMed ID: 15507673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular biology of chronic myeloid leukemia.
    Maru Y
    Int J Hematol; 2001 Apr; 73(3):308-22. PubMed ID: 11345196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alu and translisin recognition site sequences flanking translocation sites in a novel type of chimeric bcr-abl transcript suggest a possible general mechanism for bcr-abl breakpoints.
    Martinelli G; Terragna C; Amabile M; Montefusco V; Testoni N; Ottaviani E; de Vivo A; Mianulli A; Saglio G; Tura S
    Haematologica; 2000 Jan; 85(1):40-6. PubMed ID: 10629590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second case of CML with aberrant BCR-ABL fusion transcript (e8/a2) with insertion of an inverted ABL intron 1b sequence.
    Sugimoto T; Ijima K; Hisatomi H; Murayama T; Mizuno I; Hato A; Imoto S; Nishimura R; Koizumi T
    Am J Hematol; 2004 Oct; 77(2):164-6. PubMed ID: 15389825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Two Ph chromosome positive chronic myelogenous leukemia patients with rare bcr/abl fusion gene].
    Qin YZ; Liu YR; Li JL; Wang H; Chang Y; Fu JY; Ruan GR; Shi HL; Qiu JY; Lu DP; Chen SS
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):409-12. PubMed ID: 15355693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel types of bcr-abl transcript with breakpoints in BCR exon 8 found in Philadelphia positive patients with typical chronic myeloid leukemia retain the sequence encoding for the DBL- and CDC24 homology domains but not the pleckstrin homology one.
    Martinelli G; Amabile M; Giannini B; Terragna C; Ottaviani E; Soverini S; Saglio G; Rosti G; Baccarani M
    Haematologica; 2002 Jul; 87(7):688-94; discussion 694. PubMed ID: 12091118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex chromosome rearrangements may locate the bcr/abl fusion gene sites other than 22q11.
    Sessarego M; Fugazza G; Bruzzone R; Ballestrero A; Miglino M; Bacigalupo A
    Haematologica; 2000 Jan; 85(1):35-9. PubMed ID: 10629589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two patients with novel BCR/ABL fusion transcripts (e8/a2 and e13/a2) resulting from translocation breakpoints within BCR exons.
    How GF; Lim LC; Kulkarni S; Tan LT; Tan P; Cross NC
    Br J Haematol; 1999 May; 105(2):434-6. PubMed ID: 10233416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of the breakpoint in the ABL gene in cases with BCR/ABL transcript lacking ABL exon a2.
    Iwata S; Mizutani S; Nakazawa S; Yata J
    Leukemia; 1994 Oct; 8(10):1696-702. PubMed ID: 7934165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia.
    Foroni L; Gerrard G; Nna E; Khorashad JS; Stevens D; Swale B; Milojkovic D; Reid A; Goldman J; Marin D
    Am J Hematol; 2009 Aug; 84(8):517-22. PubMed ID: 19544476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic myelogenous leukemia with e13a3 (b2a3) type of BCR-ABL transcript having a DNA breakpoint between ABL exons a2 and a3.
    Liu LG; Tanaka H; Ito K; Kyo T; Ito T; Kimura A
    Am J Hematol; 2003 Dec; 74(4):268-72. PubMed ID: 14635208
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.